Shruti Setia, Sankar Nath Sanyal
Index: J. Environ. Pathol. Toxicol. Oncol. 31(1) , 27-37, (2012)
Full Text: HTML
9,10-Dimethyl benz(a)anthracene (DMBA), when injected intratracheally once at a dose of 20 mg/kg body weight, is found to induce lung cancer in rats. Two nonsteroidal anti-inflammatory drugs (NSAIDs), indomethacin and etoricoxib, are given orally daily as chemopreventive agents at a dose of 0.6 mg/kg body weight and 2 mg/kg body weight, respectively, along with DMBA. Morphologic and histologic analysis revealed the occurence of tumors and intense cellular proliferation in the DMBA-treated animals, whereas no such features were observed in the other groups. Nuclear factor κB, a nuclear transcription factor, and proliferating cell nuclear antigen, a cell proliferation antigen, were studied by immunoblotting and immunohistochemistry and their levels were markedly elevated in the DMBA group compared with the others. Oxidative stress parameters, as studied by the inducible nitric oxide synthase activity, and the levels of reactive oxygen and nitrogen species were found to be suppressed in the DMBA group. Furthermore, fluorescent staining of the isolated lung cells from bronchoalveolar lavage was performed to study apoptosis and alterations in the mitochondrial membrane potential, and the DMBA-induced lung cancer was found to be associated with high inner mitochondrial membrane potential and a suppressed level of apoptosis.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
etoricoxib
CAS:202409-33-4 |
C18H15ClN2O2S |
Analgesic activity of Eugenia jambolana leave constituent: a...
2014-08-01 [Pharm. Biol. 52(8) , 1069-78, (2014)] |
Downregulation of NF-κB and PCNA in the regulatory pathways ...
2012-10-01 [Mol. Cell Biochem. 369(1-2) , 75-86, (2012)] |
Angiostatic role of the selective cyclooxygenase-2 inhibitor...
2012-09-01 [Biomed. Pharmacother. 66(6) , 474-83, (2012)] |
Evaluation of a single preoperative dose of etoricoxib for p...
2012-12-01 [Acta Orthop. 83(6) , 642-7, (2012)] |
Etoricoxib: a highly selective COX-2 inhibitor.
2005-05-01 [Ann. Pharmacother. 39(5) , 854-62, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved